Datametrex AI Ltd (PK) (DTMXF)

Datametrex Announces Completion of AI-Based Evaluation of 2 Patents and Launch of Licensing InitiativeJune 30, 2026 8:00 AM
ACCESS NewswireTORONTO, ON / ACCESS Newswire / June 30, 2026 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC:DTMXF) is pleased to announce that its wholly owned subsidiary, QuantIP Licensing Corp. (formerly Paymetrex Payment Solutions Inc.), has completed an evaluation of 2 patents from its intellectual property portfolio using 2 artificial intelligence-driven patent analytics platforms.The evaluation focused on U.S. Patent No. 9,275,015 and U.S. Patent No. 9,665,561, both of which claim a 2012 priority date and relate generally to systems and methods for analyzing large volumes of information, including temporally ordered datasets such as social media, electronic communications, and other digital information sources. The Company notes that techniques for clustering and organizing large volumes of social media and other digital communications data have become foundational to the development and training of large language models. LLMs depend on the ingestion, organization, and semantic analysis of temporally ordered datasets - including social media content - to develop language understanding and generate contextually relevant outputs. Management believes that the methods described in the Company's patents, which address the organization and analysis of such datasets using clustering and semantic analysis techniques, are pertinent to processes that are now widely employed in the development and operation of LLM-based applications.These patents are expected to expire in 2032, subject to any patent term extensions that may be granted by the USPTO. The patents were analyzed using the proprietary evaluation methodologies of Pelent AI and VisiLeap, 2 artificial intelligence-driven patent analytics platforms. No fees were paid by the Company in connection with these evaluations. The assessments considered factors including technological relevance, claim strength, commercial applicability, and potential licensing opportunities. These AI-generated analyses were used as one of several inputs in management's evaluation of the Company's intellectual property strategy, alongside internal technical review and market analysis.Greg Waite, CEO of InventonShare and the inventor of the VisiLeap platform, has indicated that, in his view, the patents relate to techniques that have been adopted across a number of artificial intelligence and data analytics applications. Mr. Waite's opinion was provided in his capacity as the developer of the VisiLeap platform and should be read in that context. The Company intends to explore licensing opportunities with organizations whose products or services may utilize technologies that may fall within the scope of the Company's patent portfolio.Based on these evaluations, QuantIP has initiated preparations for a structured licensing program. No potential licensees have been identified, no licensing discussions are underway, and no infringement analyses have been completed as of the date of this release. There is no assurance that the licensing program will result in executed agreements or generate revenues.The licensing initiative is intended to complement QuantIP's existing intellectual property monetization activities and reflects the Company's broader strategy of leveraging artificial intelligence to identify commercialization opportunities across its intellectual property assets. The Company intends to utilize AI-assisted patent intelligence tools together with conventional licensing analysis to identify potential licensing candidates and evaluate complementary intellectual property acquisition opportunities."Artificial intelligence is becoming an increasingly useful tool for evaluating intellectual property portfolios," said Michael Kron, Chief Operating Officer of Datametrex AI Limited. "The analyses generated by Pelent AI and VisiLeap, combined with our own internal review, support management's decision to proceed with a structured licensing program in relation to these patents. We intend to use AI-driven patent intelligence tools as one component of our licensing process."The Company's two information analytics patents address technologies for organizing, analyzing, and identifying relationships within large volumes of digital information using semantic analysis, temporal organization, clustering, and trend identification techniques. Management believes these techniques continue to be relevant across a range of software applications, including enterprise analytics, cybersecurity, digital communications, and information management. The Company intends to conduct further analysis to identify specific sectors and organizations where licensing may be applicable.About QuantIP Licensing Corp.QuantIP Licensing Corp., a wholly owned subsidiary of Datametrex AI Limited, is focused on the acquisition, development, licensing, and monetization of intellectual property relating to payment technologies, artificial intelligence, cybersecurity, data analytics, and emerging quantum encryption applications.About InventionShareInventionShare monetizes technologies directly through licensing or acquisition. The Company identifies and cultivates attractive monetization opportunities by leveraging its unique toolbox of capabilities that includes:Relationships. An extensive network of high-value industry connections.Analysis. Big data tools such as VisiLeap for analyzing patents to assess technology strength and fit with target markets and companies.Marketing. Crafting compelling IP marketing stories and IP branding that is tailored for specific audiences.About DatametrexDatametrex is an innovative leader in Technology Solutions, Artificial Intelligence, and Healthcare. The Company specializes in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.For more on Datametrex, please visit our Company website (www.datametrex.com).For Additional InformationPaul Haber, C.P.A., C.A., C.Dir
CEO & Chairman

Datametrex Secures New Nutanix Infrastructure Contracts as Enterprise Data Centre Modernization AcceleratesJune 3, 2026 8:00 AM
ACCESS NewswireTORONTO, ON / ACCESS Newswire / June 3, 2026 / Datametrex AI Limited (the "Company" or "Datametrex") (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to announce that it has secured multiple enterprise infrastructure contracts totaling approximately CAD $1.8 million related to Nutanix-based data centre modernization initiatives. The Company anticipates net profit of approximately 10% from these contracts.The contracts include the upgrade and replacement of enterprise server infrastructure and associated implementation services designed to enhance performance, scalability, and operational efficiency within customers' data centre environments.Datametrex continues to expand its infrastructure business by delivering Nutanix-based hyperconverged infrastructure ("HCI") solutions that simplify data centre operations while improving reliability, scalability, and resource utilization. These modernization projects provide customers with a flexible technology foundation capable of supporting future business growth and evolving computing requirements.Paul Haber, CEO of Datametrex, commented:"We are pleased to have secured these infrastructure contracts and to continue supporting our customers' data centre modernization initiatives. These projects reflect our ongoing efforts to provide infrastructure solutions and implementation services that address our customers' operational requirements."Datametrex remains committed to expanding its enterprise infrastructure business and recurring services platform while supporting customers' evolving technology requirements through scalable and cost-effective solutions.About DatametrexDatametrex is an innovative leader in Technology Solutions, Artificial Intelligence, and Healthcare. The Company specializes in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.For more on Datametrex, please visit our website at www.datametrex.com.For Additional InformationPaul Haber, C.P.A., C.A., C.Dir
CEO & Chairman

Datametrex AI Announces Completion Of Hilco Global Patent Portfolio Qualification ReviewJune 1, 2026 8:00 AM
ACCESS NewswireTORONTO, ON / ACCESS Newswire / June 1, 2026 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC:DTMXF) is pleased to announce that Hilco Global has completed its initial qualifying due diligence review of the patent portfolio owned by the Company's wholly owned subsidiary, Paymetrex Payment Solutions Inc. ("Paymetrex").The review was conducted pursuant to a contingency based collaboration between Paymetrex and Hilco Global announced on April 8, 2026. The collaboration is focused on evaluating and pursuing potential monetization opportunities associated with Paymetrex's intellectual property portfolio.Following completion of its review process, Hilco Global has advised Paymetrex that the portfolio demonstrates relevance across multiple payment technology categories, including the rapidly expanding SoftPOS (software point-of-sale) and mobile payment acceptance market.Hilco Global further advised that the portfolio has successfully passed its internal qualification process for advancement into a structured licensing initiative. Based on the current review timeline, the parties anticipate that a broader licensing program may commence within approximately two months."The completion of Hilco Global's qualification process represents an important milestone in the advancement of our patent monetization strategy," said Michael Kron, COO of Datametrex AI Limited. "We are encouraged by Hilco Global's assessment regarding the relevance of the portfolio, particularly in relation to evolving software-based payment technologies and the growing SoftPOS ecosystem.""Hilco Global's review process is designed to assess commercial relevance, licensing viability, and strategic positioning across large addressable markets," said Eric Hurwitz, Senior Director of the Hilco Global IP Services practice. "Based on our due diligence, we believe the Paymetrex portfolio warrants advancement into a broader licensing initiative, and we look forward to working collaboratively with the Company as the program progresses."SoftPOS technology enables merchants to accept contactless payments directly on smartphones and NFC-enabled devices without dedicated payment terminals. Industry adoption of software-based payment acceptance has accelerated in recent years, driven by financial institutions, fintech providers, and payment processors seeking scalable, lower-cost merchant enablement solutions, according to multiple industry reports and payment network publications.The Company cautions that the licensing initiative remains ongoing and exploratory in nature. There can be no assurance that any licensing agreements, royalty arrangements, or other commercial outcomes will result from the anticipated program.About Datametrex AI LimitedDatametrex AI Limited (TSXV:DM)(FSE:D4G)(OTC:DTMXF) is a technology company focused on artificial intelligence, cybersecurity, and emerging infrastructure technologies. Through its subsidiaries, including Paymetrex Payment Solutions Inc., the Company is pursuing opportunities in payment technologies, secure transaction systems, and intellectual property monetization.About Hilco GlobalHilco Global, a subsidiary of ORIX Corporation USA, is a diversified financial services company that delivers integrated professional services and capital solutions that help clients maximize value and drive performance across the retail, commercial and industrial, real estate, manufacturing, brand and intellectual property sectors, and more. Hilco Global provides a range of customized solutions to healthy, stressed, and distressed companies to resolve complex situations and enhance long-term enterprise value. Hilco Global works to deliver the best possible result by aligning interests with clients and providing strategic advice and, in many instances, the capital required to complete the deal. Hilco Global is based in Northbrook, Illinois and has more than 810 professionals operating on four continents. Visit www.hilcoglobal.com.For further information, please contact:Karen Bubrowski
SVP, Brand Marketing and Communications, Hilco Global

Imagine Health Achieves Teaching Facility Status Through University of Calgary Faculty PartnershipMay 22, 2026 8:00 AM
ACCESS NewswireTORONTO, ON / ACCESS Newswire / May 22, 2026 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC:DTMXF) is pleased to announce that its wholly-owned subsidiary, Imagine Health Medical Clinics Ltd. ("Imagine Health" or "IH"), has officially established its Calgary Capitol Hill clinic site as a teaching facility following the onboarding of Dr. Michael Tam as a walk-in physician.Dr. Tam is a member of the University of Calgary faculty and will be bringing medical residents to Imagine Health's Calgary clinic as part of his practice. This affiliation represents a significant milestone for the Company, as the clinic's designation as a teaching facility is expected to strengthen Imagine Health's long-term physician recruitment and retention strategy across its clinic network in Edmonton and Vancouver."We are very pleased to welcome Dr. Tam to our team and to reach this important milestone for Imagine Health. Establishing our Calgary clinic as a teaching facility deepens our ties to the academic medical community and positions us to better attract and retain physicians across our growing network of clinics," said Paul Haber, CEO of the Company.The Company believes that its affiliation with the University of Calgary faculty will enhance the quality and continuity of care at its clinics while supporting the broader growth of Imagine Health's operations across Western Canada.Imagine Health is also pleased to address the growing need for rheumatology services in Calgary. According to the Alberta Health Services Alberta Referral Directory, the estimated wait time for a routine rheumatology appointment in the Calgary Zone currently exceeds 18 months. "We are pleased to announce that Rheumatologist Dr. Richard Akintayo is now accepting referrals at our Calgary clinic, with the hope of reducing those wait times for patients in our community," said Bonnie Adamson, Executive Director of Imagine Health Medical Clinics.Imagine Health Medical continues to bring new physicians to our clinics with the hope of reducing the stress on emergency centres. In Edmonton, we are pleased to announce that Dr. Kennedy Uzodinma has joined our clinic; he will be seeing walk-in patients as well as accepting new family medicine patients starting June 1, 2026.About Imagine HealthImagine Health Medical Clinics is a multidisciplinary medical clinic with clinics located in Edmonton and Calgary that offers a comprehensive range of healthcare services under one roof. With a commitment to quality and accessibility, Imagine Health provides family medicine, pharmacy services, and specialized medical services, including Women's Health, mental health support, and much more. With a dedicated team of healthcare professionals, Imagine Health Medical Clinics is dedicated to meeting the diverse healthcare needs of the community.To learn more, please visit: https://www.imaginehealthmedical.com/.About DatametrexDatametrex is an innovative leader in Technology Solutions, Artificial Intelligence, and Healthcare. The Company specializes in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.For more on Datametrex, please visit our website at www.datametrex.com.For Additional InformationPaul Haber, C.P.A., C.A., C.Dir
CEO & Chairman

Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 ConglomerateApril 9, 2026 7:30 AM
ACCESS NewswireTORONTO, ON / ACCESS Newswire / April 9, 2026 / Datametrex AI Limited (the "Company" or "Datametrex") (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to announce the receipt of Purchase Orders (P.O.'s) with the total value of approximately $6,000,000 from an International Fortune 500 conglomerate for data centre expansion and optimization. These significant orders further supports the Company's land-and-expand strategy and strengthens its position in AI-driven data centre operations and infrastructure solutions.The order totals approximately $6,000,000 in revenue, with an estimated profit margin of approximately 25%, consisting of approximately $5,000,000 from software licensing and $1,000,000 from technical support and maintenance services. The contracts are structured over a five-year term, with $2,000,000 payable upfront upon signing, followed by $1,000,000 payable annually in January of each year over the remaining term. These P.O.'s cover the above-mentioned services across the customer's private cloud and data center environments, leveraging its AI-driven capabilities to enhance system performance, efficiency, and resource utilization.The P.O.'s reflects ongoing customer confidence in the Company's data centre operations- related solutions, managed services platform, and private cloud infrastructure solutions, and further contributes to building a predictable and recurring revenue base as enterprise customers continue to scale their private cloud environments.Paul Haber, CEO of Datametrex, commented, "Securing approximately $6 million of Purchase Orders represent a clear validation of the strength of our strategic partnerships and our ability to consistently deliver high-impact, enterprise-scale infrastructure solutions. This achievement reflects our disciplined execution, operational strength, and our proven ability to generate meaningful, long-term value within our growing enterprise customer base. This milestone further accelerates our global growth strategy as we continue to expand our high-value infrastructure services and deepen our market presence in data centre space, positioning the Company for sustained growth and long-term value creation."The Company continues to execute on its global growth strategy, leveraging its expertise in AI-driven technologies, enterprise software, and infrastructure solutions to support large-scale clients across Asia and beyond.About DatametrexDatametrex is an innovative leader in Technology Solutions, Artificial Intelligence, and Healthcare. The Company specializes in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.For more on Datametrex, please visit our website at www.datametrex.com.For Additional InformationPaul Haber, C.P.A., C.A., C.Dir
CEO & Chairman

Datametrex Subsidiary PayMetrex Highlights Strategic Relevance of Patent Portfolio to Rapidly Expanding SoftPOS MarketMarch 19, 2026 8:00 AM
ACCESS NewswireTORONTO, ON / ACCESS Newswire / March 19, 2026 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) today announced that its wholly owned subsidiary, Paymetrex Payment Solutions Inc. ("Paymetrex"), and AnywhereCommerce Inc., on March 17, 2026, entered into a royalty-bearing license relating to Paymetrex's patent portfolio.Paymetrex's portfolio includes multiple issued U.S. and Canadian patents covering secure transaction processing, payment authorization workflows, and integrated mobile-based acceptance architectures. Specifically, Paymetrex believes portions of its patent portfolio may be relevant to certain emerging software-based payment acceptance solutions currently being deployed in the market, namely SoftPos.SoftPOS technology enables merchants to accept contactless payments directly on smartphones and NFC-enabled mobile devices without the need for dedicated hardware terminals.Industry adoption of software-based payment acceptance has accelerated significantly in recent years, driven by financial institutions, fintech providers, and global payment processors seeking scalable, low-cost merchant enablement solutions (Source: ABI Research "SoftPOS and Tap to Phone: Payment Acceptance Goes Software First"). The scope of this acceleration has been highlighted in multiple industry reports. For example, according to Juniper Research, the global value of SoftPOS transactions is projected to reach $540 billion by 2030, up from $22.9 billion in 2025 (Source: SoftPos Transactions to Accelerate by 2,150% in value by 2030; Redefining On-the Go Transactions for Small Businesses) reflecting rapid adoption across both developed and emerging markets. In this same report, Juniper Research, notes that tap-on-phone solutions are expected to play a significant role in expanding merchant acceptance infrastructure worldwide.AnywhereCommerce has a broad network of customers and well established track record in the payments industry. It is currently deploying SoftPos based solutions and will be leveraging this license in the SoftPOS (software point-of-sale) and tap-on-phone market."We believe that our patent portfolio may be relevant to software-based payment acceptance technologies said Paul Haber, CEO of Datametrex. By joining forces with AnywhereCommerce our shareholders may benefit from the ongoing expansion of Anywhere Commerce's SoftPOS solutions, in the payments marketplace. Paymetrex intends to leverage AI-driven analytics tools, including its partnership with Pelent AI, to further assess market alignment and prioritize licensing opportunities within the mobile payments ecosystem to the benefit of itself and Anywhere Commerce."About PaymetrexPaymetrex Payment Solutions Inc., a subsidiary of Datametrex AI Limited, is focused on integrating next-generation payment technologies for modern businesses. In addition to delivering secure and versatile payment solutions to merchants across North America, Paymetrex is actively pursuing the monetization of its proprietary intellectual property through a structured licensing program.About DatametrexDatametrex is an innovative leader in Technology Solutions, Artificial Intelligence, and Healthcare. The Company specializes in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.About AnywhereCommerceFounded in 2006, AnywhereCommerce provides a complete range of certified card readers, mobile apps, gateway connectivity, developer tools and customized services. It brings innovative mobile solutions to merchant service providers, developers, ISVs and enterprises.For more on Datametrex, please visit our Company website (www.datametrex.com).For Additional InformationMichael Kron, C.P.A., C.A.
Chief Operating Officer

Datametrex Received $500,000 Purchase Order For Data Centre SolutionsFebruary 13, 2026 8:35 AM
ACCESS NewswireTORONTO, ONTARIO / ACCESS Newswire / February 13, 2026 / Datametrex AI Limited (the "Company" or "Datametrex") (TSXV:DM)(FSE:D4G)(OTC:DTMXF) is pleased to announce that it has received a Purchase Order ("P.O.") of approximately $500,000 from a major Fortune 500 client based in South Korea for data centre operations and infrastructure solutions on February 6, 2026.With an estimated profit margin of approximately 20%, this P.O. supports Datametrex's ongoing commercialization of its hyperconverged infrastructure ("HCI")-based data centre operations and managed services platform, which enables private cloud services within the organizations. The Company's integrated infrastructure and technical support solutions are designed for significant cost savings and to enhance scalability, performance, and operational efficiency for enterprise clients requiring AI-enabled infrastructure and advanced computing environments.Paul Haber, CEO of Datametrex, commented, "This purchase order reflects continued enterprise demand for scalable, AI-driven infrastructure solutions. Datametrex Korea remains instrumental in delivering high-performance data centre infrastructure services tailored to the evolving requirements of large organizations. We are focused on disciplined execution, operational excellence, and expanding a predictable, recurring revenue base as we grow our global infrastructure and managed services platform."The Company's commercialization strategy is designed to support long-term growth through integrated infrastructure solutions and recurring managed services engagements as demand for AI-enabled infrastructure, GPU optimization, and intelligent data centre operations continues to expand.About DatametrexDatametrex is an innovative leader in Technology Solutions, Artificial Intelligence, and Healthcare. The Company specializes in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.For more on Datametrex, please visit our website at www.datametrex.com.For Additional InformationPaul Haber, C.P.A., C.A., C.Dir
CEO & Chairman

Eventually on this one

No.one has posted here in 7 months...32 Milly shares...this one could? Obviously A.I,any specific catalysts?

DM, new 52 week low

DM (DTMXF on the OTC): effective Feb. 19,2025 a one for 30 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

hmmmmmmmmmmmm

PARTNER HOLDS 15 MIL SHARES \\// $REGRF



partner





PARTNER HOLDS 15 MIL SHARES \\//

[-chart]www.stockscores.com/chart.asp?TickerSymbol=REGRF&TimeRange=180&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=&Band=&avgType1=&movAvg1=&avgType2=&movAvg2=&Indicator1=None&Indicator2=None&Indicator3=None&Indicator4=None&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen[/chart]

partner


[-chart]www.stockscores.com/chart.asp?TickerSymbol=DTMXF&TimeRange=180&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=&Band=&avgType1=&movAvg1=&avgType2=&movAvg2=&Indicator1=None&Indicator2=None&Indicator3=None&Indicator4=None&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen[/chart]

$DTMXF HOLDS 15 MILLION SHARES OF $REGRF IS THE MOVE EARLY FRIDAY

Symbol
REGRF
Last





$0.0388
Change
+$0.0188 (+94.00%)
Bid
$0.0200
Ask
$0.0575
High
$0.0388
Low
$0.0250
Volume
93,148
Time (ET)
09:36:28 AM

DATAMETREX AI LIMITED 2024 Annual And Special Meeting
Vote by ?November 7, 2024?.

As a shareholder in DATAMETREX AI LIMITED, you have the right to vote in an important election that may affect your investment. Don't miss your chance to make your choice.

Meeting date: ?November 13, 2024?

I SEE TRADES, EUROPE,

https://www.ariva.de/aktien/datametrex-ai-ltd-aktie/kurse/handelsplaetze

$DTMXF HOLDS 15 MILLION SHARES OF REGRF, PLUS.

balance sheet $DTMXF
https://www.otcmarkets.com/otcapi/company/financial-report/393593/content
In June 2023, the Company granted 29,500,000 stock options with an exercise price of $0.08 expiring on June 9, 2025.
The options vested immediately. The fair value was calculated to be $1,052,338 using the Black-Scholes option pricing
model with the following assumptions: (1) expected life of the option: 2 years, (2) expected volatility: 78%, (3) expected
dividend yield: 0%, and (4) risk-free interest rate: 4.36%.
In August 2023, the Company granted 5,000,000 stock options with an exercise price of $0.07 expiring on August 14,
2025.

The options vested immediately. The fair value was calculated to be $160,857 using the Black-Scholes option
pricing model with the following assumptions: (1) expected life of the option: 2 years, (2) expected volatility: 81%, (3)
expected dividend yield: 0%, and (4) risk-free interest rate: 4.64%.
During the period ended December 31, 2023, the Company recorded stock-based compensation of $1,213,194 (2022 -
$Nil) related to stock options.

Warrants
On June 18, 2023, a total of 60,000,000 warrants with an exercise price of $0.26 expired. As of December 31, 2023, there
were no warrants issued and outstanding.

Capital management
The Company manages its capital to ensure that it will be able to continue as a going concern while maximizing the return
to stakeholders through a suitable debt and equity balance appropriate for an entity of the Company’s size and status. The
Company’s overall strategy remains unchanged from the prior year.

The capital structure of the Company consists of shareholders’ equity, which totaled $10,328,553 at December 31, 2023
(December 31, 2022 - $22,768,645). The availability of new capital will depend on many factors including positive stock
market conditions, results of operations thereby access to suitable debt products, and the experience of management. The
Company is not subject to any external covenants on its capital.

Acquisitions
Ronin
In January 2019, the Company issued a statement of claim in the Ontario Superior Court of Justice against various vendors
in connection to the Ronin Blockchain Corp. Transaction (“Ronin Vendors”). Some of the defendants have counterclaimed
for shares of the Company allegedly owing under the share purchase agreement, under which the Company acquired Ronin
Blockchain Corp. (subsequently dissolved), as well as damages. The action and counterclaim have not proceeded beyond
the close of pleadings. On March 12, 2019, the Company entered into a final settlement with a 25% owner of the Ronin
Vendors, and issued 2,000,000 common shares in satisfaction of an aggregate of $100,000 of indebtedness. As at
December 31, 2023 and December 31, 2022, claims against the Company from the remaining Ronin Vendors amounted to
a balance of $1,875,000, which is included in “Provisions”.
EVS
In June 2022, the Company completed the acquisition of EVS, an arm’s length privately held electric vehicle charging
solution company incorporated under the laws of the Province of British Columbia, and issued 66,666,667 common shares
(note 10) valued at $9,333,333. The acquisition of EVS was accounted as an asset acquisition. The purchase price of
$9,333,333 was allocated as follows:
Purchase price $ 9,333,333
Patents and developed technologies (note 5) $ 4,272,000
Consideration paid in excess of asset acquired $ 5,061,333
The Company has accounted for the transaction as an asset acquisition under the scope of IFRS 2, Share Based Payments.
Consideration consisted entirely of shares of the Company which were measured at the fair value of assets acquired.
Management determined the fair value of the patents and developed technologies based on an external valuation. The
difference between the fair value of the common shares issued of $9,333,333 and the fair value attributed to the identifiable
intangible assets of $4,272,000 did not meet the criteria for recognition as an asset and consisted of unidentifiable goods
or services, which were recognized at $5,061,333 in profit or loss.
On November 13, 2023, the Company entered into an agreement related to the sale of EVS to New World. Pursuant to the
agreement, New World agreed to acquire EVS for an aggregate purchase price of up to $3,750,000, contingent upon EVS
achieving certain milestones.
The Company may receive up to an additional $3,000,000 in Earn-Out Payments contingent
upon EVS’s fulfillment of certain post-closing performance metrics. Included in amounts receivable at December 31, 2023
was $750,000 related to this sale. The sale resulted in a loss on deconsolidation of $1,972,624, which included cash balance
of $240, intangible assets of $1,419,000, property and equipment of $1,374,542, prepaids and other assets of $228,645 and
accounts payable and accrued liabilities of $299,803.
Imagine Health
In November 2022, the Company entered into a Share Purchase Agreement under which the Company acquired all of the
issued and outstanding shares of Imagine Health located in Calgary, Alberta and Edmonton, Alberta. The purchase price
was as follows: cash payment of $1,300,000 (paid), issuance of 5,000,000 common shares of the Company (issued) (note
10) and the issuance of a secured vendor take-back note with a principal amount of $800,000 payable in installments of 6,
12, and 18 months from the date of issuance (the “Note”) (note 8). The Note is secured by the assets of Imagine Health.
In addition, the Share Purchase Agreement includes a covenant to expand Imagine Health by way of working and growth
capital contribution of up to $1,000,000 to Imagine Health over a period of 12 months from the date of the acquisition.

Subsequent events
In January 2024, the Company granted 22,100,000 restricted share units (“RSU”) in accordance with the Company’s
omnibus incentive plan to employees, directors, and consultants of the Company. Each RSU entitles the holder to acquire
one Common Share on vesting, and the RSUs vest 50% effective immediately, and 50% on April 15, 2024.

The Plan was
approved by the shareholders of the Company at the Annual and Special Meeting Shareholders on December 14,2023.
In February 2024, the Company granted 12,500,000 RSUs to employees, directors, and consultants of the Company.

Each RSU entitles the holder to acquire one Common Share on vesting, and the RSUs vest 12 months from the date of grant.
In February 2024, the Company closed the non-brokered private placement of 50,000,000 units of the Company at a price
of $0.02 per unit for aggregate gross proceeds of $1,000,000.

Each Unit consists of one (1) common share of the Company
("Share") and one (1) common share purchase warrant ("Warrant").
Each Warrant entitles the holder to acquire one
additional Share of the Company at a price of $0.05 per Share for a period of two (2) years from the date of issuance. In
connection with the Private Placement, the Company paid cash finder's fees of $3,200 and issued 160,000 broker warrants
("Broker Warrants") on gross proceeds raised by eligible arm's length parties. Each broker Warrant is exercisable to acquire
one Share of the Company at a price of $0.05 for a period of two (2) years. Insiders of the Company have participated in
the Private Placement by subscribing for 5,250,000 Units.

I HAVE READINGS ON PARTNER $REGRF POSSIBLE $5.00/$6.00 PER SHARE.

AND THE POSSIBILITES FOR $DTMXF

SOME VOLUME TODAY, DM DataMetrex AI Limited
0.01
0.005 (100.00%)
Volume: 1,714,230
Day Range: 0.005 - 0.01
Last Trade Time: 11:40:37 AM EDT

$DTMXF \\// REMEMBER THEY HOLD 15.000,000 SHARES OF $REGRF [REGRF UNLIMITED POSSIBILITIES

I LIKE POSSIBILITES FOR $DTMXF

The possibilities are endless with Datametrex' AI ,,, endless ????? E. V. R. ,,, MEDICAL ,,,

The possibilities are endless with Datametrex' AI ,,, endless ????? E. V. R. ,,, MEDICAL ,,,


https:// www.youtube.com/watch?v=ApFk3sWAXtg

ANOTHER---


https:// youtu.be/PNqFKiIrSxA

About Datametrex


Datametrex is an innovative leader in Technology Solutions, Artificial Intelligence, Healthcare, and Mobile Gaming.
The Company excels in delivering tools and solutions that enhance operational efficiencies and business outcomes.
With a commitment to innovation,
Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.

READY AIM GO FOR THE MONEY

https://www.stockscores.com/charts/charts/?ticker=DM

https://www.stockscores.com/charts/charts/?ticker=DTPKF

https://www.stockscores.com/charts/charts/?ticker=DM

https://www.stockscores.com/charts/charts/?ticker=DTPKF

[-chart]www.stockscores.com/chart.asp?TickerSymbol=DTPKF&TimeRange=180&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=1100&ChartHeight=480&LogScale=&Band=&avgType1=&movAvg1=&avgType2=&movAvg2=&Indicator1=None&Indicator2=None&Indicator3=None&Indicator4=None&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen[/chart]

https://www.energyandcapital.com/investing-in-graphene/

Yes , True, now 15% $DTMXF ... SHAREHOLDER OF REGRF

do you know what money used for ?????

two links u.s.a. & canada
https://www.tradingview.com/symbols/OTC-DTMXF/?utm_campaign=tickers&utm_medium=widget_new&utm_source=www-datametrex-com.filesusr.com

https://www.tradingview.com/symbols/TSXV-DM/?utm_campaign=tickers&utm_medium=widget_new&utm_source=www-datametrex-com.filesusr.com

two links u.s.a.
https://www.tradingview.com/symbols/OTC-DTMXF/?utm_campaign=tickers&utm_medium=widget_new&utm_source=www-datametrex-com.filesusr.com

https://www.tradingview.com/symbols/OTC-DTMXF/?utm_campaign=tickers&utm_medium=widget_new&utm_source=www-datametrex-com.filesusr.com

DIVISIONS

https://static.wixstatic.com/media/bbc9ac_9609b8581f744b0f9fe7c1ca7d0c97cb~mv2.png/v1/fill/w_798,h_560,al_c,q_90,usm_0.66_1.00_0.01,enc_auto/icon2.png

newbie $DTMXF

yes on $DM

after .031 coming nothing - lloks good

may tmr more - let`s gooooo
imo

looks here very super good https://www.otcmarkets.com/stock/DTMXF/quote

imho

super UPTREND CHART now

$DTMXF is now hot - looks epic WEEEEEEEEEEEEEEE🔥

Great volume and first comes volume increase and then price increase.
imo

[in Germany moving up https://www.ariva.de/datametrex_ai_ltd-aktie/kurse/handelsplaetze

https://www.stockscores.com/charts/charts/?ticker=DTMXF

sounds good

Nice volume on this AI play, with a great opportunity to load the dip yesterday, green today.

Prior to the Disposition, Datametrex held approximately 18.33% of New World's outstanding common shares. Afterwards, it holds approximately 14.53%.

Destined for sub's?

One cent now.

New Press Release

https://www.newsfilecorp.com/release/131458/DM-EVS-Partners-with-Commercial-Landlords-and-Developers-in-Canada

An interesting Foundation is being-Built-here

This might prove interesting in a few years IMO